Prognostic Value of NLR, TLR, and ALC in Predicting ToF Primary Repair Outcome

Clinical trial NCT05976204 · COMPLETED

Trial details

NCT number: NCT05976204
Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia
Status: COMPLETED
Study type: OBSERVATIONAL

Congenital Heart Disease Tetralogy of Fallot Neutrophil-lymphocyte Ratio Absolute Lymphocyte Count Thrombocyte-lymphocyte Ratio Outcome TOF

Start date: 2020-01-01
Primary completion: 2022-12-31
Enrollment: 501

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.